Meet in Italy for Life Sciences Brokerage Event 2026

13 – 14 Oct 2026 | Roma, Italy

InvestmentUpdated on 17 September 2026

ELEMENTARy - funding opportunities

Associate Researcher at Istituto Auxologico Italiano

Milan, Italy

About

ELEMENTARY offers a proprietary preclinical screening platform built on patient-derived tumor models specifically developed for rare endocrine cancers, a disease area currently underserved by standard drug discovery pipelines. The platform is designed to identify compounds with direct clinical translatability, significantly reducing the gap between preclinical screening and early-phase clinical application. The platform is currently in validation phase on MTC, with a clear development roadmap toward the broader NET space.

ELEMENTARY is seeking pre-seed investment to complete the platform validation phase on MTC and progress toward more rare endocrine cancers.

Stage

  • Pre-seed funding | Idea validation

Similar opportunities